2m 2m 2m 2m 2m 2m 2m
Glaukos (GKOS)
NYSE
$167.27+$0.01 (+0.009%)
Price as of Sep 11, 2026 7:30 PM EDT- $9.9BMarket Cap
- 102.09%1-Year Change
- Medical DevicesIndustry
Glaukos (GKOS)
$167.27+$0.01 (+0.009%)
GKOS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $167.25 | ||
Change | -$3.13 (-1.84%) | ||
Open | $174.12 | ||
High | $175.38 | ||
Low | $166.74 | ||
Previous Close | $170.38 | ||
Volume | 552,313 | ||
30-Day Average Volume | 652,156 | ||
1-Week Change | -5.76% | ||
1-Month Change | -8.10% | ||
1-Year Change | 102.09% | ||
3-Year Change | 120.15% | ||
5-Year Change | 219.36% | ||
Fundamentals | |||
Shares Outstanding | 59.0M | ||
Total Assets | $920.5M | ||
Market Cap | $9.9B | ||
Enterprise Value | $9.8B | ||
Period: QTR TTM FY | |||
Revenue | $185.6M | ||
Net Income | -$18.4M | ||
Free Cash Flow | $12.1M | ||
EBIT | -$17.7M | ||
EBITDA | -$11.8M | ||
Net Working Capital | $413.4M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | -823 | ||
Enterprise Value/Revenue | 53 | ||
P/B | 14 | ||
P/E | -540 | ||
PEG | -61 | ||
Price/Free Cash Flow | 816 | ||
Price/Operating Cash Flow | 666 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue